Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

8.0%

6 terminated/withdrawn out of 75 trials

Success Rate

91.4%

+4.9% vs industry average

Late-Stage Pipeline

7%

5 trials in Phase 3/4

Results Transparency

91%

58 of 64 completed trials have results

Key Signals

3 recruiting58 with results5 withdrawn

Enrollment Performance

Analytics

N/A
57(91.9%)
Phase 4
3(4.8%)
Phase 3
2(3.2%)
62Total
N/A(57)
Phase 4(3)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (75)

Showing 20 of 75 trials
NCT06739811Not ApplicableRecruiting

Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)

Role: lead

NCT07408141Recruiting

MiniMed Fit Payload Wear Study

Role: lead

NCT07228117Not ApplicableRecruiting

GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Role: lead

NCT06645834Not ApplicableCompleted

Smart MDI Study (CIP343)

Role: lead

NCT07227805Not ApplicableNot Yet Recruiting

Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Role: lead

NCT06604871Not ApplicableCompleted

Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

Role: lead

NCT02748018Not ApplicableCompleted

Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home

Role: lead

NCT05224258Not ApplicableCompleted

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

Role: lead

NCT05574062Not ApplicableCompleted

Evaluation of the MiniMed 780 System in Paediatric Subjects

Role: lead

NCT06719531Not ApplicableWithdrawn

SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Diabetes

Role: lead

NCT06838819Not Yet Recruiting

CGM in Icodextrin PD

Role: collaborator

NCT05714059Not ApplicableCompleted

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Role: lead

NCT05325294Not ApplicableCompleted

Evaluation of the Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adults and Pediatrics Utilizing Lyumjev®

Role: lead

NCT03959423Not ApplicableCompleted

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Role: lead

NCT04809285Not ApplicableCompleted

Use of the Guardian™ Connect System With Smart Connected Devices

Role: lead

NCT04308291Completed

The MiniMed™ 780G Glycemic Control and Quality of Life Study for the Treatment of Pediatric and Adult Subjects With Type 1 Diabetes in France.

Role: lead

NCT05029271Not ApplicableCompleted

InPen User Experience

Role: lead

NCT04304963Completed

Hypo-METRICS: Hypoglycaemia - Measurement, ThResholds and ImpaCtS

Role: collaborator

NCT04964128Not ApplicableCompleted

Evaluation of Meal Gesture Dosing in Adults With Type 1 Diabetes

Role: lead

NCT04378114Not ApplicableCompleted

Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults

Role: lead